FOXA vs PROF · P/E 14, $24.50B cap vs rev $10.7M
Fox Corp Class A (FOXA) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
FOXA does not have a complete income-statement cache yet.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. PROF currently screens at market cap $238.7M.
Not investment advice. Open the FOXA and PROF stock pages for the full models.
Not investment advice.